Understanding how host factors and hundreds of viral genes orchestrate the complex life cycle of herpesviruses represents a fundamental problem in virology. Here, we use CRISPR/Cas9based screening to scan at high-resolution for functional elements in the genome of human cytomegalovirus (HCMV), and to generate a genome-wide mapping of host dependency and restriction factors. Our data reveal an architecture of functional modules in the HCMV genome, and host factor pathways involved in virus adhesion and entry, membrane trafficking, and innate immune response. Single-cell analysis shows that the large majority of cells follow a stereotypical trajectory in viral gene expression space. Perturbation of host factors does not alter this trajectory, but can accelerate or stall progression. Conversely, perturbation of viral factors creates discrete alternate 'dead-end' trajectories. Our results reveal a fundamental dichotomy between the roles of host and viral factors in orchestrating viral replication and more generally provide a road map for high-resolution dissection of host-pathogen interactions.
The betaherpesvirus HCMV is a pervasive pathogen that establishes lifelong infection in the majority of the human population. Activation of its lytic cycle triggers a characteristic cascade of events, starting with stereotypical waves of viral gene expression, continuing with the replication of the large, 235 kb dsDNA genome, and culminating in the budding of newly assembled virions. A number of systematic studies have described these phenomena on the level of the transcriptome, the set of translated messages, and the proteome in time and space (1) (2) (3) (4) (5) (6) . These studies have highlighted the complexity of the process and have raised the question of how hundreds of viral genes cooperate to manipulate the host and undermine its defense machinery. CRISPR technology provides us with tools to systematically measure the functional contribution of each viral gene and to identify the host factors involved in productive infection (7) . Here, we present systematic screens for both host and viral factors affecting HCMV infection in primary human fibroblasts. To capture the complexity of the molecular events during infection, we recorded the transcriptomes of tens of thousands of single cells, monitoring how perturbation of critical host and viral factors alters the timing, course, and progression of infection. Our data paint an unprecedented picture of the HCMV life cycle and its vulnerabilities to antiviral intervention.
High resolution functional landscape of the HCMV genome
It was recently shown that targeting individual essential herpesvirus genes by CRISPR/Cas9 disrupts their expression di-rectly and their function through errors introduced by the host DNA repair machinery (8) . Cleavage of the viral DNA in non-essential regions has a moderate impact on genes proximal to the cut site, but minimal impact on HCMV replication and host cell viability, likely because DNA repair is fast relative to the kinetics of replication ((8) and our data below). Thus, Cas9 represents an effective tool for making targeted disruptions in the viral genome. To enable high-resolution scanning of viral elements for a comprehensive functional annotation of the HCMV genome, we designed a single-guide RNA (sgRNA) library that targets every protospacer-adjacent motif (PAM) for S. pyogenes Cas9 (NGG PAM sequence present roughly every 8 bp) along the genome of the clinical HCMV strain Merlin (Fig. 1A , Table S1 ). We delivered the library into primary human foreskin fibroblasts engineered to express Cas9, so that upon HCMV infection, each cell executes a cut at a defined position along the viral genome, collectively tiling its entirety.
We mapped the phenotypic landscape by quantifying the abundances of individual sgRNA cassettes in cells surviving infection relative to the initial population by deep sequencing ( Fig. S1 ). We found that cutting phenotypes are relatively constant within individual genes, i.e. the determining factor is which gene is targeted by Cas9, more so than the relative position of the target site within the gene. Adjacent sets of genes also frequently had similar phenotypes. However, some gene boundaries were marked by abrupt phenotype changes, arguing that here, strong functional consequences of Cas9-induced double-strand breaks are limited to the immediate vicinity of the cut sites (Figs. 1B, S2, Table  S1 ).
At a larger scale, changes in the direction and magnitude of the phenotypes defined six major genomic modules: Cuts in both distal regions of the genome, which lack genes essential for viral replication (9, 10) , had minimal impact on host cell survival. As expected, targeting the two regions covering UL48A-UL73 and UL96-UL150, both of which contain essential genes involved in viral DNA replication, packaging and nuclear egress (9, 11) , strongly protected infected cells from death. Surprisingly, in the two remaining regions of the genome, we found that disruption of genes required for viral replication did not necessarily protect the host from death. Cuts within the UL32-UL47 region, which contains essential genes, led to a strongly increased ability of the virus to kill cells. The most strongly sensitizing phenotypes mapped to the known viral apoptosis inhibitors UL36, UL37, and UL38 (12) . While this behavior can be rationalized for virally Our HCMV tiling library or genome-wide human sgRNA libraries were lentivirally delivered into primary human foreskin fibroblasts expressing the CRISPRi or CRISPRn machinery, followed by infection with HCMV. sgRNA cassettes were quantified by deep sequencing in the initial (t0) population, the surviving population, and the uninfected control population. (B) Phenotypic landscape of the HCMV genome obtained by locally averaging the phenotypes of individual sgRNAs. Strong changes in the magnitude of the phenotype coincide with gene-gene boundaries (inset). (C) Results of host-directed CRISPRi screen displayed as a scatter plot of average gene essentiality (i.e. infection-independent phenotype; y-axis) vs. protection/sensitization to death upon HCMV infection (i.e. infection-dependent phenotype; x-axis). encoded anti-apoptotic proteins, it extended to many other virus-essential genes without known anti-apoptotic roles, including the DNA polymerase processivity factor UL44. Similarly, cuts in the central region spanning UL75-UL88 led to slightly enhanced host cell death upon infection. Many genes in this region are encoding essential structural components of the viral envelope, tegument, and capsid. Targeting essential viral genes, by definition, undermines the production of viral offspring. The outcome for the host, however, is more nuanced and sometimes counterintuitive. It appears that disrupting essential genes involved in viral DNA replication mostly protects the host. However, interfering with the later steps of assembling new virions may not only be ineffective for protecting the host, but even place an additional burden, leading to enhanced host cell death.
Genome-wide screen for host factors of HCMV infection
Next, we carried out a screen for host factors modulating HCMV infection by systematically repressing expression of human genes by CRISPR interference (CRISPRi) (13, 14) . Phenotypes were defined by enrichment or depletion of sgRNA cassettes in the surviving cell population over the initial population, as well as in an uninfected control population to account for host gene essentiality (Fig. 1C , Table  S2 ).
Our screen revealed a range of diverse host genes required for multiple steps in the viral life cycle. Genes involved in the biosynthesis of heparan sulfate were among the strongest protective hits. Heparan sulfate proteoglycans on the cell surface enable the adhesion of HCMV prior to cell entry (15, 16) . Additionally, we found a range of vesicle trafficking factors: RAB6A and its GEFs RIC1/KIAA1432 and RGP1, the conserved oligomeric Golgi (COG) complex, members of TRAPP complex III, and UNC50. These factors converge on the Golgi apparatus and mediate both retrograde and anterograde transport, implying that they act downstream of viral entry. Some had previously been implicated in the internalization of diverse bacterial and plant toxins, suggesting that HCMV and toxins exploit similar pathways for cell entry (13, (17) (18) (19) (20) (21) . Other protective hits included members of the LAMTOR/Ragulator complex, Folliculin (FLCN), and the Lyspersin (C17orf59) subunit of the BORC complex, all linked to lysosome positioning and nutrient sensing (22) (23) (24) . This supports and extends the recent observation that HCMV infection changes lysosome dynamics (6) . Addition-ally, host cell death was reduced by knockdown of certain Cullin-RING E3 ligases, adaptor subunits, substrate receptors, regulators, and the associated neddylation and deneddylation machineries. Many viruses, including HCMV, hijack this pathway to degrade host restriction factors, which can be prevented by broadly-acting NEDD8-activating enzyme inhibitors (25, 26) . Finally, we identified genes involved in tail-anchored protein insertion into the ER, as well as ER-associated degradation: AMFR, an E3 ligase, and the TRC40/GET pathway members BAG6 and ASNA1, which were shown to be required for insertion of membrane proteins of herpes simplex virus I which, however, lack HCMV orthologs (27) . Our screens also identified a number of host factors whose knockdown sensitizes cells to death upon infection rather than protecting them. Among these were known restriction factors such as PML and DAXX, as well as members of the interferon type I (IFN) pathway. We also found subunits of the NuA4 histone acetyltransferase complex, which was shown to counteract Hepatitis-B virus (28) . Other sensitizing hits included members of the signal recognition particle, the translocon and associated factors, and genes involved in ER stress (29, 30) . Finally, we found genes with anti-apoptotic function, whose removal likely increases the sensitivity to apoptosis triggered by HCMV infection. To validate and extend the host factors identified in the CRISPRi screen, we conducted a knockout screen using an established CRISPR cutting (CRISPRn) library (31) ( Fig.  S3A , Table S2 ). The CRISPRi and CRISPRn screens were in general agreement ( Fig. S3B ). However, the phenotypes of hits involved in virus entry, as well as pro-and anti-apoptotic genes, were more pronounced in the knockout screen, consistent with the notion that selection pressure acts more strongly on cells with true null alleles compared to cells with residual expression of targeted genes. PDGFRA stood out as the top protective hit, supporting its described role as HCMV entry receptor in fibroblasts (32) (33) (34) (35) . Conversely, genes that are essential for host viability and factors with weaker phenotypes were often not enriched above background in the CRISPRn screen. One reason may be the toxicity of DNA cutting per se, especially in a cell type with an intact p53 response (36, 37) . Our findings underscore the benefits of combining orthogonal modes of genetic screening (38) .
The lytic cascade resolved by single-cell transcriptomics
Our pooled screens provide a genome-scale picture of the factors involved in lytic HCMV infection. To investigate the roles of critical host and viral factors in more detail, we used Perturb-seq, which combines CRISPR-based genetic perturbations with a rich transcriptional readout at the single-cell level (29, (39) (40) (41) . Measuring tens of thousands of singlecell transcriptomes provides a massively parallel way of testing large numbers of genetic perturbations under controlled conditions with a high-dimensional readout. The single-cell nature of this approach makes it particularly well suited for studying virus infection, a process with great inherent vari-ability from cell to cell (42) (43) (44) (45) (46) . To lay the groundwork for the Perturb-seq analysis, we explored the spectrum of cellular states in response to infection by recording single-cell transcriptomes from cells sampled from eight time points with two multiplicities of infection each ( Fig. 2A ). Instead of synchronizing cells experimentally, which has inherent limits to its resolution due to intrinsic heterogeneity in the timing at which individual cells are infected and the rate of progression of the infection, we staged cells computationally by their transcriptional signatures. The largest sources of variability between cells were the extent of IFN signaling and the viral load, i.e. the fraction of viral transcripts per cell, which reached levels of around 75 % and was positively correlated with total cellular RNA content ( Fig. S4 ). Together, these properties define three main subpopulations of cells: a naïve population (uninfected and IFN-negative); a bystander population (uninfected and IFN-positive); and an infected population with varying amounts of viral transcripts ( Fig. 2B ). Of note, while activation of IFN-stimulated genes (ISGs) and early viral gene expression happen at the same experimental time points, they are almost entirely segregated to different populations of cells, and only a small cohort of cells with low viral loads also express ISGs. This phenomenon may present itself as an apparent correlation of some viral genes with ISGs in bulk measurements, but has been described in single-cell studies of herpes simplex virus 1 (4, 45) . Together, this underscores the rapidity with which the virus actively suppresses IFN signaling (see S4B). When looking at viral gene expression, we found that after an initial noisy phase, the majority of infected cells followed a dominant and highly stereotypical trajectory with increasing viral load. A subpopulation of around 2 % of cells, however, followed an alternate trajectory ( Fig. 2C ). Staging cells in silico for each trajectory enabled us to calculate high-resolution expression patterns of individual viral genes as a function of a 'pseudo-temporal' axis defined by viral load. Hierarchical clustering of individual viral transcripts along the dominant trajectory broadly recapitulated the established classes of 'immediate-early', 'delayed-early', 'leaky-late' and 'truelate' genes, but with a high degree of pseudo-temporal fine structure within each class ( Fig. 2D, S5 ) thus providing a far higher resolution view of these waves. In agreement with the classification based on proteomics measurements (4), we defined an additional 'intermediate' kinetic pattern. The alternate trajectory, followed by ∼2 % of cells, was characterized by a uniform increase of early genes, an almost complete absence of true-late transcripts and of the otherwise abundant major non-coding RNAs and generally low total cellular RNA content, indicating that this trajectory is abortive ( Figs. 2E, S5 ). The pattern of expressed genes showed no enrichment of specific genomic loci, arguing against the hypothesis that this subpopulation might be infected by virions with defined long-range genomic defects ( Fig. S5 ). Focusing on the patterns of host gene expression as a function of viral load, we found that once interferon signaling is halted in early-infected cells, most host transcripts behave coherently as viral load increases ( Fig. S6 ). HCMV, unlike other herpesviruses, is known to allow translation of host transcripts to proceed selectively (47) . Some housekeeping transcripts (e.g. those of ribosomal proteins) decreased in abundance, suggesting that they are being actively suppressed (48, 49) . A small but prominent set of host transcripts were upregulated, including CD55, which was previously seen at the protein level (4) and shown to be incorporated into budding virions to counteract the complement system (50) .
Only cells in the G1 phase of the cell cycle are permissive to the progression of infection (51) . Accordingly, we observed that G1 cells are gradually depleted from the population of uninfected cells, and a majority of infected cells adopt a G1like state (Fig. S7A, B ). Most cells later abruptly switched to a state most resembling S-phase. This transition co-occurs with the onset of 'true-late' gene expression, which marks the beginning of viral genome replication (see Fig. S5B ) and likely reflects the pseudo-mitotic state described for cells in late-stage infection (52).
Host and virus-directed genetic perturbations lead to conceptually different outcomes
We next conducted a series of Perturb-seq experiments exploring the impact of targeting either host or viral factors on the viral replication cycle. In contrast to the pooled screen, where phenotypes emerge by enrichment or depletion of cells over multiple days, Perturb-seq provides a high-resolution view of the impact of targeting a viral or host gene over the ∼72 h course of a single viral replication cycle. We first selected 52 host genes with protective or sensitizing phenotypes identified in the pooled screens ( Fig. 3A, B , Table S3 ). We monitored how perturbing them by CRISPRi changes the host cell transcriptomes and the propensity of cells to get infected when challenged with HCMV at a low multiplicity of infection (MOI) ( Fig. 3C, D) . In uninfected cell populations, we observed the strongest transcriptional responses with knockdown of LAMTOR/Ragulator subunits and the neddylation machinery, as well as mild responses to the knockdowns of vesicle trafficking factors, and of genes associated with the translocon. The patterns of the transcriptional responses to the knockdowns organized host factors by biological pathway in a principled fashion (Fig. 3C ). This required no prior knowledge and provided a layer of informa- SEC62  SEC61B  SEC63  BCL2L1  VTCN1  TRAF2  IFNAR2  IRF9  STAT2  control  LAMTOR1  LAMTOR4  LAMTOR5  LAMTOR3  LAMTOR2   AMFR  WDR26  KXD1  C17orf59  FAM126A   CUL3  NEDD8  NAE1  UBA3  RBX1  DDA1  DCAF4  CASP2  CASP9  CASP3  CYCS  HCCS  KIRREL  KIAA1432  RAB6A  RGP1  BAG6  ASNA1  TRAPPC8  TRAPPC12  TRAPPC11   COG2  COG8  COG5  UNC50  LARGE  B4GALT7  SLC35B2 EXT2 GLCE HS6ST1 tion that would have remained unresolved when ranking hits simply by their phenotypes in the pooled screens. The transcriptional patterns were mostly similar in naïve cells compared to the bystander population, however, knockdown of IFN pathway members prevented cells from mounting the response characteristic of bystander cells (Fig. S8 ). The Perturb-seq data also revealed the proportion of cells that remained uninfected after HCMV challenge (Fig. 3D ). The results correlated broadly with the low-resolution view obtained in the pooled screen; for example, knockdown of interferon pathway members led to a strong increase in the numbers of infected cells. In order to follow changes in viral gene expression in infected cells, we next carried out a Perturb-seq experiment where we challenged cells with a high MOI of HCMV. We used CRISPRn, allowing us to target viral genes in addition to host factors. Based on their strongly protective or sensitizing phenotypes in the pooled, virus-directed screen, we selected 31 viral gene targets, in addition to a representative set of 21 host factors, for which we verified that knockdown and knockout trigger comparable host responses ( Fig. 4A, B , Table S3 , Fig. S9 ).
We found that the time course of progression of infection varied widely depending on the targeted gene ( Fig. 4C ). Control cells gradually transitioned from being predominantly earlystage to predominantly late-stage. Perturbation of host factors caused shifts in this bimodal distribution ( Fig. 4C , left panel). For example, knockout of PDGFRA (the proposed viral receptor (33)) or HS6ST1 (involved in heparan sulfate biosynthesis) prevented any accumulation of viral transcripts. Similarly, no appreciable quantities of viral tran-scripts were found in cells lacking COG8 or UNC50, implicating these factors as novel components required for viral entry. Perturbation of Ragulator/LAMTOR and FLCN, as well as RIC1/KIAA1432 and RGP1, allowed infected cells to initially progress to early-stage, but then caused a stall. This suggests these factors act downstream of viral uncoating but prior to viral genome replication. Conversely, blocking the interferon pathway caused an acceleration of progression, with most cells reaching late-stage prematurely, at 48 h post-infection. Finally, knockout of pro/anti-apoptotic host genes, among others, barely changed the viral load distribution compared to the negative controls, suggesting that rather than impacting the course of infection itself, these interfere with the ability of the virus to kill the cells in a way that is not immediately apparent at the transcript level.
Compared to targeting host genes, targeting viral genes typically led to qualitatively different outcomes. The distributions of viral loads were no longer bimodal, but multimodal ( Fig. 4C , right panel), prompting us to monitor the underlying patterns of individual viral genes, rather than looking at viral genes in aggregate by way of the viral load ( Fig. 4D ). In the space of viral gene expression, all trajectories defined by cells with perturbed host genes were nearly congruent with the control trajectories, indicating that host genes do not determine the patterns of viral gene expression at the different stages of infection ( Fig. 4D, top) . Rather, host-directed perturbations determine which stage of infection can be reached and how quickly. In marked contrast, when we targeted viral genes, infection progressed along radically distinct trajectories in expression space that diverge from the default and fall into a set of classes (Fig. 4D, sgRNAs targeting non-essential regions of the viral genome followed the same trajectory as those with host-targeting controls, showing only mild transcriptional effects on genes in the vicinity of the cut sites (Figs. S10, S11). Alternate trajectories were arranged in three main bundles (Fig. 4E, F) : The first class of trajectories was established by targeting genes in the strongly sensitizing region (UL35-UL43). Here, the number of cells declined rapidly with increased viral load, in agreement with the higher susceptibility to cell death upon infection found in the pilot screen (Fig.  S10 ). In addition to creating a pro-apoptotic state, a surprising feature of these alternate trajectories was the failure to shut down expression of immediate-early and delayed-early genes once later stage genes were expressed (Fig. 4F) . A second bundle corresponded to perturbations of genes in the first strongly protective module (UL52-ORFL152C), as well as UL102 and UL105. These trajectories showed a marked delay and reduced induction of true-late genes, with few cells reaching high viral loads, indicating a failure to replicate the viral genome. A third bundle contained perturbations of genes located within the UL115-UL148 region. This bundle was most similar to the unperturbed trajectories. Of note, the kinetics of progression varied between the targeted genes within this group (Fig. 4C, right) , with perturbation of the major immediate-early transactivator genes UL122 and UL123 causing the strongest delays. Finally, cells with perturbations of UL69 and UL112, genes with comparatively weak protective phenotypes, defined two trajectories distinct from the three main bundles, despite their genome positions adjacent to or within genes belonging to the main bundles ( Fig. 4F ). Targeting UL69 caused overexpression of RNA1.2, while targeting of UL112 triggered widespread deregulation of genes from all temporal classes (Figs. 4E, S10) . Taken together, this shows that adherence to the normal viral trajectory is orchestrated by a diversity of viral genes, but not host factors.
Discussion
The waves of viral gene expression during lytic infection are a key signature of herpesvirus biology and its molecular players are subjects of intense investigation (53) . Here, we introduce a functional single-cell genomics approach to study lytic HCMV infection with unprecedented temporal and gene expression resolution. We combine comprehensive pooled CRISPR screening, directed against both host and virus, with massively parallel single-cell transcriptional analysis of infection. Together, this strategy identifies genes critical for infection and pinpoints their specific roles by observing the changes in the course of infection when each factor is perturbed.
Our study redefines the lytic cascade at the single-cell level as a highly resolved continuum of cellular states, which would otherwise be obscured by differences in the kinetics of infection in bulk experiments. We find that the large majority of cells follow this stereotypical trajectory in viral gene expression space, while a small but prominent subpopulation take an alternate, abortive trajectory.
Most importantly, we reveal a dichotomy in how the system reacts to host-versus virus-directed perturbations: Targeting critical host factors alters how fast or how far cells can progress along the lytic cascade. If the lack of a factor stalls progression, this directly reveals the phase at which this factor plays a critical role. Conversely, targeting viral factors can alter the course of infection by creating defined and specific alternate trajectories that do not necessarily culminate in successful replication or that drive cells into premature apoptosis. This dichotomy, may be a general feature of virus-host systems. HCMV is entirely dependent on the transcriptional and translational machinery of its host. At the same time, our findings indicate that the lytic cascade is a deterministic program, which, once set in motion, is solely controlled by viral factors.
Our work also provides a roadmap for the design of effective antiviral combination therapies by selecting sets of targets that drive the virus into distinct, nonproductive pathways while sparing or inducing apoptosis in the host, depending on the desired outcome. Similarly, our data can inform the design of engineered attenuated viral strains for vaccine development purposes. More generally, we envision that our approach can serve as a blueprint for studying other viruses and to define their vulnerabilities to genetic or pharmacological interventions.
Materials and Methods

Cell and virus culture
Human foreskin fibroblasts (HFFs; CRL-1634) and HCMV (strain Merlin; VR-1590) were purchased from the American Tissue Culture Collection. HFFs were cultured in DMEM, supplemented with 10 % FBS and penicillin-streptomycin. HCMV stocks were expanded by two rounds of propagation on HFFs and titered by serial dilution. For stable expression of the CRISPRi/n machineries in HFFs, we modified established lentiviral (d)Cas9 expression vectors (13) by inserting a minimal ubiquitous chromatin opening element (UCOE) (54) upstream of the SFFV promoter, resulting in pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB) and pMH0004 (UCOE-SFFV-Cas9-BFP). The UCOE prevented epigenetic silencing that affected the original constructs.
Pooled CRISPR screening
The HCMV tiling library was designed to contain sgRNAs targeting every single of the 33,465 PAMs in the HCMV Merlin genome (NCBI NC_006273.2), as well as 533 non-targeting controls (Table S1 ). It was synthesized and cloned into a lentiviral vector (Addgene #84832) as previously described (13, 14) . For targeting host genes, we used the human CRISPRi v2 library (Addgene #83969) (14) , and the K. Yusa et al. human knockout CRISPR v1 library (Addgene #67989) (31), respectively. Libraries were packaged into lentiviruses and delivered into (d)Cas9-expressing HFFs at an MOI of 0.3-0.5, followed by puromycin selection. Pooled screens were carried out at 500-1,000 × coverage, i.e. ∼500-1,000 cells per library element per sample taken. A t 0 sample was harvested and the remaining cells either passaged normally, or infected with HCMV at an MOI of 0.5-1.0 (for the HCMV tiling screens) or 0.1 (for the host-directed screens). Infected flasks were washed with PBS and given fresh media at days 3, 5, 7 post infection to remove dead cells, and harvested at day 9-10. Genomic DNA was extracted and digested with MfeI (pCRISPRia v2-based libraries) or HindIII (Yusa et al. library) to release a fragment containing the sgRNA cassette, followed by gel-based extraction, PCR amplification and deep sequencing as described (14) . Raw count data were normalized for read depth and a small constant added to account for missing values. Phenotypes of individual sgRNAs were expressed as log 2 -transformed ratios of adjusted read counts between samples (Table S2 ). We calculated the mean of all sgRNAs specific to each host gene. For the HCMV tiling screen, we calculated a rolling average in a 200 bp window, with the average of all non-targeting sgRNAs defining the baseline.
Single-cell RNA-seq
For the single-cell infection time course, WT HFFs were lentivirally transduced with barcoded Perturb-seq vectors to encode the experimental condition (pBA571, Addgene #85968; Table S3 , sheet 2), followed by puromycin selection. Cells were seeded at a density of 250,000 per well of a 12-well plate and infected with an MOI of 0.5 (low) or 5.0 (high). Infection times were staggered so that all time points for a given MOI were harvested in parallel, pooled, prepared for single-cell transcriptomics using one lane each of the Chromium Single Cell 3 Gene Expression Solution v2 according to manufacturer's instructions (10x Genomics), and sequenced on a NovaSeq platform (Illumina) at ∼100,000 reads/cell. Barcodes encoding the experimental condition were PCR-amplified from the final library and sequenced separately as described (29) .
Perturb-seq
For the host-directed CRISPRi Perturb-seq experiment, we initially selected 53 candidate genes by their strong protective or sensitizing phenotypes in the pooled screen (one gene was later removed during analysis, see below). We manually picked the two best performing sgRNAs for each candidate. Additionally, we added six non-targeting control constructs (targeting GFP, which is not present in our HFFs). For the host-and virus-directed CRISPRn Perturb-seq experiment, we selected a set of 21 host factors, of which 19 were already among the targets CRISPRi Perturb-seq experiment, had no strong essentiality knockout phenotypes and comparable protective or sensitizing phenotypes in both the pooled host-directed CRISPRi and CRISPRn screens (see Fig. S3 ). We further added PDGFRA and FLCN, both of which were strong hits in the pooled CRISPRn screen. For each host target, we manually picked the two best performing sgRNAs. In addition, we selected 31 viral targets with strong protective or sensitizing phenotypes, corresponding to the three strongest modules identified in the HCMV tiling screen (see Fig. S2 ). From the tiling screen, we selected the two highest-ranking sgRNAs for each target gene based on the following scoring system: From the pool of unique sgRNAs falling within the gene boundaries and having a Doench score (55) of >0.5, we calculated the absolute average phenotype across replicates and subtracted a penalty defined as the difference between replicates plus the average absolute essentiality phenotypes (on a log 2 scale). We designed a number of safe-targeting control sgRNAs targeting intergenic DNA in the US2-US12 region. This region was selected based on its near-neutral phenotypes in the tiling screen (Fig. S2 ), a lack of essential genes (9, 10), and its comparatively large spaces between consensus genes. Further, in some bacterial artificial chromosome (BAC) constructs harboring HCMV genomes, this region has been replaced by the BAC backbone, underlining its non-essential nature during infection in tissue culture (56) . We picked five sgRNAs based on their Doench scores from a pool of unique sgRNAs targeting the intergenic regions and having survival and essentiality phenotypes of <0.5 (log 2 scale) in all replicates. In addition, we included four control sgRNAs directed against safe-harbor loci in the host genome that we repurposed from gene knock-in applications.
All sgRNAs were synthesized as individual oligo pairs (IDT) and cloned into a barcode library containing plasmid pool (pBA571, Addgene #85968), thereby linking each sgRNA to a unique guide barcode contained within the 3 -UTR of the puromycin resistance gene (29) . Barcodes were validated to not contain homo-oligomers or sequences resembling transcription termination signals. All sgRNA and barcode sequences are listed in Table S3 . sgRNAs vectors were packaged into lentiviruses individually, titered separately and pooled to ensure equal representation. We delivered the library into (d)Cas9-expressing HFFs at an MOI of 0.3 followed by puromycin selection. Cells were seeded at 250,000 per well of a 12-well plate and infected with HCMV at an MOI of 0.5 (for the CRISPRi host-directed experiment) or 5.0 (for the CRISPRn host and virus-directed experiment). Cells were harvested in the uninfected state (0 h) and at 24, 48 and 72 h.p.i. We aimed at a representation of each sgRNA by ∼100 cells per time point. Cells were collected and prepared for sgRNA-seq using the 10x Chromium platform as described above for the single-cell infection time course. Libraries were sequenced on a HiSeq4000 or NovaSeq platform (Illumina) at ∼40,000 reads/cell.
Single-cell data analysis
Raw sequencing data were submitted to 'cellranger' (10x Genomics) according to the manufacturers instructions. We compiled a reference transcriptome from the hg19 human genome and a custom assembly of HCMV coding transcripts based on our previous ribosome profiling dataset (3) as distributed as part of the 'Plastid' python library demo dataset (57) . We manually added four well-established lncRNA transcripts (RNA1.2, 2.7, 4.9, 5.0). Internal ORFs were removed as they would create ambiguous mappings, as were ORFs overlapping with the aforementioned lncRNAs. Cells retained in the final dataset had to cross the default cellranger quality thresholds, as well as have one unique lentiviral barcode assigned with high confidence (29) . During data analysis of the perturb-seq experiments, three CRISPRn sgRNAs targeting host genes were removed computationally because they were found to be inactive, as seen by lack of transcriptional responses and viral load patterns similar to control sgRNAs. One host gene, RBBP5, was similarly excluded from both the CRISPRi and CRISPRn datasets as it became apparent that its knockdown/knockout causes differentiation of cells and a strong transcriptional response, rather than true protection against infection. Viral loads were calculated as the fraction of total UMIs per cell mapping to viral genes. Gene expression was normalized first in each cell by the total unique molecular identifiers (UMIs) per cell and then z-scored on a per-gene basis across all cells. Human genes represented by <10,000 UMIs across all cells, as well as viral genes represented by <5,000 UMIs were removed before hierarchical clustering. For heatmap representations of gene expression as a function of viral load, cells were binned by viral load and gene-level expression values averaged in each bin. Bin widths of 2 % or 10 % were selected depending on the available number of cells, with the lower bound indicated in the respective figures. Cell cycle phases were scored based on marker genes as described (29) . Using a similar approach we calculated an IFN score by summing and subsequently z-scoring the relative expression values of the following set of robustly quantified ISGs (PSMB8, PSMB9, PSME1, PSME2, ISG15, ISG20, IRF7, MX1, MX2, GBP1, GBP2, GBP3, IFI6, IFI44, IFI35, IFI16, IFI27,  IFIH1, IFI44L, IFIT1, IFIT2, IFIT3, IFIT5, IFITM1, IFITM2, IFITM3, EIF2AK2, OAS1, OAS2, OAS3, CNP, PLSCR1, BST2,  BTN3A2 , XAF1, CASP1, CASP4, CASP7, GSDMD). Dimensionality reduction was performed by t-SNE (58) implemented in scikit-learn (59) or UMAP (60) implemented in Monocle (61) . Trajectories were based on UMAP projections. To determine trajectories, selected cells were ranked by viral load and the geometric position of cells averaged in a sliding window that was shifted in increments of 0.2 window sizes. Window sizes were selected based on the total number of available cells: Perturb-seq experiments: 100 cells; unperturbed cells, dominant trajectory: 500 cells, alternate trajectory: 50 cells. S1 . Data processing for the HCMV tiling screen. We calculated log2 ratios of each individual sgRNA in the surviving over the t0 populations. Ratios were averaged in a sliding 200 bp window. The average of the ratios of the non-targeting sgRNA population was set as the baseline. The plot was then colored based on the sign of the average phenotype (reds: positive sign, protective phenotype; blues: negative sign, sensitizing phenotype) and layered in bands of decreasing lightness, one log2 unit wide. The negative space was mirrored on the baseline, and bands were stacked for the final horizon plot representation (62) . For high resolution see Fig. S2 . (63), causing it to be dropped from the consensus annotation), and ORFL152C were the only short ORFs with strong phenotypes in areas of the genome devoid of consensus genes. UL48 was the only gene that showed a substantial phenotype gradient within its gene body: Cutting the N-terminal region caused mild sensitization to death upon infection, whereas cutting the C-terminus had the opposite effect. 
all cells alternate trajectory cells Fig. 1B and Fig. S2 ), and by their position in the viral genome (green, unique long (UL) branch; purple, unique short (US) branch; increasing saturation towards the terminal regions). Note the relationship between a gene's temporal class and its phenotype in the pooled screen: True-late and leaky-late genes predominantly showed protective phenotypes, whereas earlier classes also contained sensitizing genes.
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